Premier Psychiatric Research Institute. LLC.
Lincoln, Nebraska 68526
0 studies enrolling now · 20 studies all time
What they study most
Adult Attention Deficit Hyperactivity Disorder, Alzheimer's Disease, Anhedonia, Attention Deficit Hyperactivity Disorder, Attention-Deficit/Hyperactivity Disorder, Attention-deficit/Hyperactivity Disorder, Depressive Disorder, Major, Generalized Anxiety Disorder, Genetics of Drug Metabolism, Insomnia, Major Depressive Disorder, Major Depressive Disorder (MDD)
Studies at this site
- A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant — Completed
- A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy — Completed
- The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder — Completed
- Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder — Completed
- Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate — Completed
- Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder — Completed
- SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
- SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder — Completed
- Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD — Completed
- Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD) — Stopped early
- Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder — Completed
- Genomics Used to Improve DEpression Decisions — Completed
- Smoking Cessation Study In Healthy Adolescent Smokers — Completed
- Dasotraline Adult ADHD Study — Completed
- A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD — Completed
- A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD — Completed
- POC Study in Partially Responsive Generalized Anxiety Disorder — Stopped early
- Utility of PharmacoGenomics for Reducing Adverse Drug Effects — Status unconfirmed
- Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44 — Completed
- Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia — Completed